Sativex for Treatment of Chemotherapy Induced Neuropathic Pain

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010

This article is included in 2 Systematic reviews Systematic reviews (2 references) 1 Broad synthesis Broad syntheses (1 reference)

This article is part of the following publication threads:
  • Lynch [provisional publication thread name] (2 documents)
This article is part of the following matrixes of evidence:
Loading references information
Chemotherapy is often used to treat cancer and in many cases can cure it or extend life. Unfortunately many of the chemotherapeutic agents used in treating cancer can cause nerve damage, resulting in severe pain involving the extremities. This \"neuropathic\" pain causes significant suffering in cancer survivors and may also limit the amount of chemotherapy patients are able to tolerate in attempting to treat the cancer. There is evidence that cannabinoids can suppress chemotherapy evoked neuropathy in animal models, in some cases better than morphine. This study proposes to examine the effect of a cannabinoid extract (Sativex) in treatment of neuropathic pain caused by chemotherapy.
Epistemonikos ID: 956ba95c7ef9e78c7d075cf31cc722b435219897
First added on: Jun 26, 2015